Skip to content

Blog

Policy and Government

Prescription Drug Price Transparency: Our Response to the Federal RFI

Serif Health recently submitted both an independent and joint coalition response to the federal government’s Request for Information on prescription drug price transparency. Drawing on our national TiC data from June 2025, we demonstrate that infrastructure already exists and offer clear recommendations to ensure that negotiated drug prices become fully visible, comparable, and actionable.

Bill Pajerowski

Published

7/15/2025

Previous Posts